Skip to Content

Oxaprozin Pregnancy and Breastfeeding Warnings

Oxaprozin is also known as: Daypro, Daypro Alta

Oxaprozin Pregnancy Warnings

Animal studies have revealed evidence of increased pre- and post implantation loss following administration of prostaglandin synthesis inhibitors during pregnancy. Infrequent malformed fetuses were observed at doses of 7.5 mg/kg/day or higher (0.1 times maximum recommended human daily dose). There are no controlled data in human pregnancy. Testicular degeneration was observed in beagle dogs treated with 37.5 mg/kg/day for 42 days or 6 months (0.7 times maximum recommended human daily dose based on body surface area). NSAIDs may impair female fertility; withdrawal of NSAID therapy should be considered in women with difficulties conceiving or who are undergoing investigation of infertility. Administration during labor and delivery is not recommended; onset of labor may be delayed and the incidence of stillbirths may increase. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Not recommended during last trimester of pregnancy. Prior to 30 weeks gestation: Use only if potential benefit justifies the potential risk to the fetus. US FDA pregnancy category: C Comments: -Avoid use during third trimester as it may cause premature closure of the ductus arteriosus. -Not recommended in women attempting to conceive as may impair female fertility.

See references

Oxaprozin Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes Comments: The effects in the nursing infant are unknown.

Due to lack of published clinical experience during breastfeeding, other agents may be preferred.

See references

References for pregnancy information

  1. "Product Information. Daypro (oxaprozin)." Searle, Skokie, IL.

References for breastfeeding information

  1. "Product Information. Daypro (oxaprozin)." Searle, Skokie, IL.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide